Lower levels of the mitochondrial protein GCDH result in Kglu of the TF NRF2, leading to cell death, indicating that GCDH pathway inhibition is a potential therapeutic strategy for melanoma treatment.565. The gene discussed is GCDH; the disease is melanoma.